Registration is required. Registration for the SAMHSA Buprenorphine Clinical Discussion WebBoard is open to physicians holding waivers from SAMHSA to practice opioid addiction treatment under the authority of the Drug Addiction Treatment Act of 2000 (DATA). If you are a physician holding a DATA waiver and would like to register for the SAMHSA Buprenorphine Clinical Discussion WebBoard, click here for the registration page. An e-mail will be sent to you to confirm your registration. You must register with the same e-mail address you provided on the Notification of Intent (NOI) you submitted to SAMHSA to obtain your DATA waiver. If you would like to register but did not provide an e-mail address on your original NOI, please contact us by e-mail at web-admin@buprenorphine.samhsa.gov.

Registrations submitted from individuals other than physicians holding DATA waivers will be declined.

For information about DATA, opioid addiction treatment with buprenorphine, or the SAMHSA Buprenorphine Clinical Discussion WebBoard, visit the SAMHSA Buprenorphine Website at http://www.buprenorphine.samhsa.gov or e-mail us at info@buprenorphine.samhsa.gov.